Cubist Systematic Strategies LLC Sells 214,292 Shares of DENTSPLY SIRONA Inc. $XRAY

Key Points

• Cubist Systematic Strategies LLC has reduced its stake in DENTSPLY SIRONA Inc. by 50.5%, now owning approximately 0.11% of the company, valued at $3,134,000.
• Other institutional investors, including Vanguard Group Inc. and Price T Rowe Associates Inc., have increased their holdings in DENTSPLY SIRONA, indicating a mixed sentiment among major shareholders.
• DENTSPLY SIRONA reported $936 million in revenue for its latest quarter, slightly exceeding expectations, but experienced a 4.9% decline in year-over-year revenue.

Cubist Systematic Strategies LLC decreased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 50.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 209,756 shares of the medical instruments supplier's stock after selling 214,292 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.11% of DENTSPLY SIRONA worth $3,134,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of XRAY. Northern Trust Corp grew its position in shares of DENTSPLY SIRONA by 14.9% in the 4th quarter. Northern Trust Corp now owns 2,082,391 shares of the medical instruments supplier's stock valued at $39,524,000 after buying an additional 269,502 shares during the last quarter. Jane Street Group LLC boosted its holdings in DENTSPLY SIRONA by 1,080.5% in the fourth quarter. Jane Street Group LLC now owns 373,423 shares of the medical instruments supplier's stock valued at $7,088,000 after acquiring an additional 341,790 shares during the last quarter. Algert Global LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $753,000. Ameriprise Financial Inc. raised its holdings in DENTSPLY SIRONA by 10.2% during the 4th quarter. Ameriprise Financial Inc. now owns 249,246 shares of the medical instruments supplier's stock worth $4,735,000 after purchasing an additional 23,053 shares during the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $576,000. 95.70% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Stifel Nicolaus decreased their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Barrington Research decreased their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a report on Friday, August 8th. Wells Fargo & Company dropped their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research note on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Finally, Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Two analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Up 1.8%

Shares of XRAY traded up $0.24 during trading hours on Thursday, hitting $13.94. The stock had a trading volume of 1,995,204 shares, compared to its average volume of 2,632,930. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.48. The firm has a market capitalization of $2.78 billion, a P/E ratio of -2.94, a price-to-earnings-growth ratio of 0.86 and a beta of 0.96. The firm has a 50 day simple moving average of $14.79 and a 200-day simple moving average of $15.08. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company's quarterly revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.6%. DENTSPLY SIRONA's dividend payout ratio is presently -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.